Australia markets closed

Amneal Pharmaceuticals Inc (2DT.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
6.200.00 (0.00%)
As of 08:06AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-168,693
-83,993
-129,986
10,624
91,059
-
Depreciation & amortisation
226,778
229,400
240,175
233,406
235,387
-
Deferred income taxes
-
-
-
0
0
371,716
Stock-based compensation
25,948
26,822
31,847
28,412
20,750
-
Change in working capital
-113,441
-47,186
-59,945
-133,593
-61,318
-
Accounts receivable
-124,854
126,289
-79,717
-23,621
16,787
-
Inventory
-115,874
-126,182
-102,396
-49,015
-113,782
-
Accounts payable
118,211
-94,446
109,568
-43,932
307
-
Other working capital
124,243
276,388
-25,495
189,181
312,815
-
Other non-cash items
39,489
44,413
17,445
15,188
19,960
-
Net cash provided by operating activities
201,455
345,577
65,100
241,820
379,001
-
Cash flows from investing activities
Investments in property, plant and equipment
-77,212
-69,189
-90,595
-52,639
-66,186
-
Acquisitions, net
-
0
-84,714
-146,543
-251,360
-
Other investing activities
-
-
1,000
5,000
-
43,017
Net cash used for investing activities
-77,212
-69,189
-174,309
-194,182
-317,546
-
Cash flows from financing activities
Debt repayment
-404,798
-414,080
-123,272
-79,179
-37,012
-
Dividends paid
0
-
-
-
-
0
Other financing activities
-223,241
-235,676
-69,010
-59,796
-11,502
-
Net cash used provided by (used for) financing activities
-222,828
-212,573
-106,620
-138,122
131,807
-
Net change in cash
-99,452
63,880
-221,512
-90,382
194,299
-
Cash at beginning of period
151,069
35,227
256,739
347,121
152,822
-
Cash at end of period
52,484
99,107
35,227
256,739
347,121
-
Free cash flow
Operating cash flow
201,455
345,577
65,100
241,820
379,001
-
Capital expenditure
-77,212
-69,189
-90,595
-52,639
-66,186
-
Free cash flow
124,243
276,388
-25,495
189,181
312,815
-